Compare ELWT & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELWT | IXHL |
|---|---|---|
| Founded | 2002 | 2001 |
| Country | United States | Australia |
| Employees | 34 | 12 |
| Industry | Telecommunications Equipment | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.5M | 39.0M |
| IPO Year | 2025 | 2024 |
| Metric | ELWT | IXHL |
|---|---|---|
| Price | $7.70 | $3.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 5.2K | ★ 70.6K |
| Earning Date | 05-15-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.37 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $21,618,000.00 | $12,000.00 |
| Revenue This Year | $28.81 | N/A |
| Revenue Next Year | $70.70 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 154.48 | N/A |
| 52 Week Low | $4.11 | $0.16 |
| 52 Week High | $9.72 | $6.39 |
| Indicator | ELWT | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 42.86 | 43.74 |
| Support Level | $6.92 | $3.07 |
| Resistance Level | $7.24 | $3.98 |
| Average True Range (ATR) | 0.22 | 0.19 |
| MACD | -0.04 | -0.04 |
| Stochastic Oscillator | 6.19 | 7.46 |
Elauwit Connection Inc is a provider of broadband Internet networks for the multifamily and student housing property sector. It designs, installs, operates, and maintains new fiber-optic and WiFi networks throughout each contracted property. Once installed, property owners begin selling Internet connectivity over Elauwit's network directly to their residents at monthly prices and terms of their choosing. Elauwit, in turn, provides all resident activation, onboarding, customer support, and network monitoring and maintenance services in exchange for a fixed monthly fee based on the number of units in the property times a monthly per-unit wholesale price. Its contracts with property owners generally have five to eight-year terms. Geographically, the company mainly operates in the U.S.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.